Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Ltd has issued an update regarding the classification of certain unquoted securities, correcting their status to fall under the company’s 7.1 capacity as per ASX Listing Rules. This adjustment ensures compliance with regulatory standards and reflects the company’s commitment to maintaining transparency and accuracy in its financial disclosures.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on developing advanced imaging solutions for respiratory diagnostics. The company is known for its innovative lung imaging technology, which aims to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 5,044,779
Technical Sentiment Signal: Buy
Current Market Cap: A$1.15B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.